These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30613324)

  • 1. Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors.
    Laiolo J; Tomašič T; Vera DMA; González ML; Lanza PA; Gancedo SN; Hodnik Ž; Peterlin Mašič L; Kikelj D; Carpinella MC
    ACS Med Chem Lett; 2018 Dec; 9(12):1186-1192. PubMed ID: 30613324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative.
    González ML; Vera DMA; Laiolo J; Joray MB; Maccioni M; Palacios SM; Molina G; Lanza PA; Gancedo S; Rumjanek V; Carpinella MC
    Front Pharmacol; 2017; 8():205. PubMed ID: 28487651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells.
    Rigalli JP; Ruiz ML; Perdomo VG; Villanueva SS; Mottino AD; Catania VA
    Toxicology; 2011 Jul; 285(1-2):18-24. PubMed ID: 21459122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototoxic effectiveness of zinc phthalocyanine tetrasulfonic acid on MCF-7 cells with overexpressed P-glycoprotein.
    Chekwube AE; George B; Abrahamse H
    J Photochem Photobiol B; 2020 Mar; 204():111811. PubMed ID: 32028187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
    Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
    Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracts of Immature Orange
    Okada N; Murakami A; Urushizaki S; Matsuda M; Kawazoe K; Ishizawa K
    Front Pharmacol; 2017; 8():84. PubMed ID: 28270768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells.
    Kota BP; Tran VH; Allen J; Bebawy M; Roufogalis BD
    Pharmacol Res; 2010 Nov; 62(5):426-31. PubMed ID: 20624464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells.
    Tan H; Xu C; Zeng H; Wang Y; Li Y; Fan X; Chen P; Jiang Y; Chen X; Huang M; Bi H
    J Pharmacol Sci; 2016 Feb; 130(2):66-71. PubMed ID: 26782648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
    Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
    Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1-overexpressing MG63/DOX cell xenograft model: maintain the MDR phenotype in vivo.
    Zhou Z; Wan L; Han Y; Meng X; Yang Q; Li Y; Yu Q; Shen Z; Guo C
    Pharm Biol; 2013 Aug; 51(8):968-73. PubMed ID: 23735077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells.
    Morsy MA; El-Sheikh AAK; Ibrahim ARN; Venugopala KN; Kandeel M
    PeerJ; 2020; 8():e9163. PubMed ID: 32566390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carbamazepine on the P-gp and CYP3A expression correlated with PXR or NF-κB activity in the bEnd.3 cells.
    Ke XJ; Cheng YF; Yu N; Di Q
    Neurosci Lett; 2019 Jan; 690():48-55. PubMed ID: 30312753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.
    Dash TK; Konkimalla VB
    Pharm Res; 2017 Aug; 34(8):1741-1750. PubMed ID: 28536971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
    Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Porcelli L; Paradiso A
    Bioorg Med Chem; 2008 Jan; 16(1):362-73. PubMed ID: 17936633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
    Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.